Physician profile
Robert Taylor
NPI 1821198052
$214.69
in general payments reported to CMS, 2019-2025
9 companies · $13.77 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $12.27 · 2024: $18.85 · 2025: $13.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $88.50 | 2019 | |
| Glaxosmithkline, LLC. | $28.93 | 2019 | |
| Sumitomo Pharma America, INC. | $18.85 | 2024 | Orgovyx |
| Mylan Specialty L.P. | $16.97 | 2019 | |
| Chiesi USA, INC. | $13.77 | 2025 | Cleviprex |
| Merck Sharp & Dohme LLC | $13.19 | 2019 | |
| Shionogi INC | $12.27 | 2020 | |
| Shire North American Group INC | $11.17 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.